FDA has not consistently shared information on conflict determinations.
New guidance is needed to enhance transparency.
Advisory committee integrity is crucial for public trust.
Briefing: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Strategic angle: A new review reveals the FDA's shortcomings in disclosing financial conflicts of interest among advisory committee members.